AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

APIXABAN 2.500 Mg ;

10 registrations across 1 African market— 10 active

Markets with APIXABAN 2.500 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
Eliquis
Film Coated Tablets
🇪🇬EgyptPfizer Biopharmaceuticals Egypt LLCactive
Artixiban 2.5 mg
Film Coated Tablets
🇪🇬EgyptThe Tenth of Ramadan for Pharmaceutical Industries & Diagnostic Reagents "RAMEDA"active
Apixatrack 2.5 mg
Film Coated Tablets
🇪🇬EgyptEva pharma for Pharmaceuticals and Medical Appliances - Eva Pharmaactive
Eliquis
Film Coated Tablets
🇪🇬EgyptPfizer Biopharmaceuticals Egypt LLCactive
Pixaspire
Film Coated Tablets
🇪🇬EgyptInspire Pharmaceutical Company IPC Pharmaactive
Endlixaban 2.5 mg
Film Coated Tablets
🇪🇬EgyptATCO Pharma for Pharmaceutical Industriesactive
Artixiban 2.5 mg
Film Coated Tablets
🇪🇬EgyptThe Tenth of Ramadan for Pharmaceutical Industries & Diagnostic Reagents "RAMEDA"active
Sagitrixan
Film Coated Tablets
🇪🇬Egyptphoenix overseas for pharmaceuticalsactive
Iksaront 2.5 mg
Film Coated Tablets
🇪🇬EgyptApex pharmaactive
Pixaspire
Film Coated Tablets
🇪🇬EgyptInspire Pharmaceutical Company IPC Pharmaactive

APIXABAN 2.500 Mg ; in Africa — Regulatory Overview

APIXABAN 2.500 Mg ; is registered across 1 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 10 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.